Avenue Therapeutics Stock Forecast

Sell candidate since Jun 12, 2026

The Avenue Therapeutics, Inc. stock price gained 6.67% on the last trading day (Friday, 12th Jun 2026), rising from $0.300 to $0.320. During the last trading day the stock fluctuated 40.00% from a day low at $0.250 to a day high of $0.350. The price has fallen in 5 of the last 10 days but is still up by 6.67% over the past 2 weeks. Volume fell on the last day by -480 shares and in total, 20 shares were bought and sold for approximately $6.40 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.62% during the next 3 months and, with a 90% probability hold a price between $0.222 and $0.749 at the end of this 3-month period.

ATXI Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Avenue Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.337 and $0.403. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 24, 2026, and so far it has fallen -51.52%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Avenue Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.300 and $0.290. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Avenue Therapeutics, Inc. finds support just below today's level at $0.300. If this is broken, then the next support from accumulated volume will be at $0.290 and $0.241.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.1000 between high and low, or 40.00%. For the last week the stock has had daily average volatility of 14.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATXI) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Avenue Therapeutics, Inc. to open at $0.307, and during the day (based on 14 day Average True Range), to move between $0.283 and $0.357, which gives a possible trading interval of +/-$0.0735 (+/-25.94%) up or down from last closing price. If Avenue Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 25.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.300 (6.25%) than the resistance at $0.350 (9.37%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Avenue Therapeutics, Inc. stock A Buy?

The Avenue Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Avenue Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.682 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $0.307 ( 4.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk